Nothing Special   »   [go: up one dir, main page]
create a website
The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014. (2019). Suleman, Fatima ; Moodley, Rajatheran.
In: PLOS ONE.
RePEc:plo:pone00:0219690.

Full description at Econpapers || Download paper

Cited: 3

Citations received by this document

Cites: 34

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Evidence on the effectiveness of policies promoting price transparency - A systematic review. (2023). van den Ham, Hendrika A ; Mantel-Teeuwisse, Aukje K ; Kotas, Eleanor ; Glanville, Julie ; Tordrup, David ; Joosse, Iris R.
    In: Health Policy.
    RePEc:eee:hepoli:v:134:y:2023:i:c:s0168851022002822.

    Full description at Econpapers || Download paper

  2. A critical review of methodologies used in pharmaceutical pricing policy analyses. (2023). van den Ham, Hendrika A ; Mantel-Teeuwisse, Aukje K ; Bero, Lisa ; Tordrup, David ; Joosse, Iris R.
    In: Health Policy.
    RePEc:eee:hepoli:v:134:y:2023:i:c:s0168851022000598.

    Full description at Econpapers || Download paper

  3. .

    Full description at Econpapers || Download paper

References

References cited by this document

  1. Aitken M, Machin C, Troein P. Understanding the pharmaceutical value chain. Pharm Policy Law [Internet ]. 2016; 18(1–4):55–66. Available from: http://www.medra.org/servlet/aliasResolver?alias= iospress&doi=10.3233/PPL-160432
    Paper not yet in RePEc: Add citation now

  2. Antoñanzas F, Terkola R, Overton PM, Shalet N, Postma M. Defining and Measuring the Affordability of New Medicines: A Systematic Review. Pharmacoeconomics. 2017; 35(8):777–91. https://doi.org/10. 1007/s40273-017-0514-4 PMID: 28477220

  3. Auta A, Bala ET, Shalkur D. Generic medicine substitution: A cross-sectional survey of the perception of pharmacists in north-central, Nigeria. Med Princ Pract. 2013; 23(1):53–8. https://doi.org/10.1159/ 000355473 PMID: 24217185
    Paper not yet in RePEc: Add citation now
  4. Bangalee V, Suleman F. Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Heal SA Gesondheid. 2016; 21:60–6.
    Paper not yet in RePEc: Add citation now
  5. Barron P. African private pharmaceutical market [Internet]. University of Pretoria; 2014. Available from: https://repository.up.ac.za/bitstream/handle/2263/41894/Barron_Management_2013.pdf?sequence=1
    Paper not yet in RePEc: Add citation now
  6. Cambourieu C, Pomey M, Cambourieu C. Generic Drug Pricing Policy in Quebec. 2013.
    Paper not yet in RePEc: Add citation now
  7. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009; 373(9659):240–9. https://doi.org/10.1016/S0140-6736(08)61762-6 PMID: 19042012
    Paper not yet in RePEc: Add citation now
  8. Cameron A, Laing R. Cost savings of switching private sector consumption from originator brand medicines to generic equivalents. World Heal Report, Backgr Pap 35. 2010;11.
    Paper not yet in RePEc: Add citation now
  9. Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value Heal [Internet]. 2012; 15(5):664–73. Available from: http://dx.doi.org/10.1016/j.jval.2012.04.004
    Paper not yet in RePEc: Add citation now

  10. Carone G, Schwierz C, Xavier A. Cost-containment policies in public pharmaceutical spending in the EU [Internet]. Economic and Financial Affairs. 2012. Available from: https://doi.org/10.2765/27111

  11. Council for Medical Schemes. CMS Annual Report 1995 [Internet]. 1995. Available from: https://www. medicalschemes.com/files/Annual Reports/CMS Annual Report 1995.pdf
    Paper not yet in RePEc: Add citation now

  12. Danzon PM, Chao L. Does Regulation Drive Out Competition in Pharmaceutical Markets? J Law Econ [Internet]. 2000; 43(2):311–58. Available from: http://www.journals.uchicago.edu/doi/10.1086/467458

  13. Deroukakis M. Mandatory generic substitution. 2007; 97(1):63–4.
    Paper not yet in RePEc: Add citation now
  14. Dias V, Henry D, Searles A. MDS-3: Managing Access to Medicines and Health Technologies. Manag Sci Heal [Internet]. 2012;Chapter 9. Available from: http://www.msh.org/resource-center/ebookstore/ copyright.cfm.%5Cnwww.mds-online.org
    Paper not yet in RePEc: Add citation now
  15. Gray A, Suleman F. Pharmaceutical Prices in South Africa [Internet]. Babar Z-U-D, editor. Pharmaceutical Prices in the 21st Century. Cham: Springer International Publishing; 2015. 251–265 p. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84943386681&partnerID=tZOtx3y1
    Paper not yet in RePEc: Add citation now
  16. Hassali MA, Alrasheedy AA, McLachlan A, Nguyen TA, AL-Tamimi SK, Ibrahim MIM, et al. The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J [Internet]. 2014; 22(6):491–503. Available from: https://doi.org/10.1016/j.jsps.2013.12.017 PMID: 25561861
    Paper not yet in RePEc: Add citation now
  17. Hollis A, Grootendorst P. Canada’s New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem. Healthc Policy [Internet]. 2015 Aug; 11(1):10–4. Available from: http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4748362/ PMID: 26571465
    Paper not yet in RePEc: Add citation now
  18. Hollis A. Generic Drug Pricing and Procurement: A Policy for Alberta. Univ Calgary Sch Policy Stud Res Pap. 2008;2(1).
    Paper not yet in RePEc: Add citation now
  19. International Federation of Pharmaceutical Manufacturers. The Pharmaceutical Industry and Global Health. 2017.
    Paper not yet in RePEc: Add citation now
  20. Kaplan W, Wirtz V, Nguyen A, Ewen M, Vogler S, Laing R. Policy Options for Promoting the Use of Generic Medicines in Low- and Middle-income Countries [Internet]. March 2016. Available from http:// haiweb.org/wp-content/uploads/2017/02/HAI_Review_generics_policies_final.pdf
    Paper not yet in RePEc: Add citation now

  21. Maisonneuve CD La, Martins JO. Public spending on health and long-term care: a new set of projections. OECD Econ Policy Pap [Internet]. 2013; 6(06):1–39. Available from: http://www.oecd.org/eco/ growth/Health FINAL.pdf

  22. Mediscor. Mediscor Medicines Review 2013 [Internet]. 2013. Available from: http://www.mediscor.net/ MMR/Mediscor%2520Medicines%25.20Review%25202013.pdf.
    Paper not yet in RePEc: Add citation now

  23. Moreno-Torres I, Puig-Junoy J, Raya JM. The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain. Eur J Heal Econ. 2011; 12(6):563–73.

  24. National Department of Health South Africa. Regulations relating to a transparent pricing system for medicines and scheduled substances [Internet]. NDoh; 2004. Available from: https://www.gov.za/sites/ www.gov.za/files/26304.pdf
    Paper not yet in RePEc: Add citation now
  25. R. V. Generic prescriptions and dispensing in India—problems and solutions—a study. World J Pharm Res [Internet]. 2017 Sep 1; 6(09):414–29. Available from: http://wjpr.net/dashboard/abstract_id/7646
    Paper not yet in RePEc: Add citation now
  26. Republic of South Africa. Medicines and Related Substances Control Amendment Act (Act 90 of 1997). 18505 South Africa: Government Gazette; 1997.
    Paper not yet in RePEc: Add citation now
  27. Seeley E, Kanavos P. Pharmaceutical Policy: cost containment and its impact [Internet]. 2008 p. 18–22. Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/80445/Eurohealth14_2.pdf
    Paper not yet in RePEc: Add citation now
  28. StataCorp. Stata Release 13 [Internet]. Vol. 161–user N. StataCorp LP; 2013. Available from: https:// www.stata.com/manuals13/u.pdf Pricing policy evaluation for South Africa for generic medicines PLOS ONE | https://doi.org/10.1371/journal.pone.0219690 July 31, 2019 17 / 20. WHO, HAI Global, WHO; HAI. Measuring medicine prices, availability, affordability and price components [Internet]. Vol. 2nd Editio, World Health Organisation. 2008. Available from: http://www.who.int/ medicines/areas/access/medicines_prices08/en/
    Paper not yet in RePEc: Add citation now

  29. Vernon JA, Santerre RE. Assessing consumer gains from a drug price control policy in the U.S. South Econ J [Internet]. 2005; 73:233–45. Available from: http://www.nber.org/papers/w11139% 0ANATIONAL Pricing policy evaluation for South Africa for generic medicines PLOS ONE | https://doi.org/10.1371/journal.pone.0219690 July 31, 2019 18 /

  30. Vogler S, Zimmermann N, Leopold C, de Joncheere K. Pharmaceutical policies in European countries in response to the global financial crisis. South Med Rev. 2011; 4(2):22–32.
    Paper not yet in RePEc: Add citation now
  31. Vogler S. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview. Generics Biosimilars Initiat J [Internet]. 2012; 1(2):93–100. Available from: http://www.gabi-journal.net/the-impact-ofpharmaceutical -pricing-and-reimbursement-policies-on-generics-uptake-implementation-of-policyoptions -on-generics-in-29-european-countries─an-overview.html
    Paper not yet in RePEc: Add citation now
  32. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002; 27(4):299–309. PMID:
    Paper not yet in RePEc: Add citation now
  33. World Health Organization. WHO Guideline on Country Pharmaceutical Pricing Policies. WHO [Internet ]. 2015;134. Available from: http://apps.who.int/iris/bitstream/10665/153920/1/9789241549035_ eng.pdf
    Paper not yet in RePEc: Add citation now
  34. Xiphu L, Mpanza N. Medicine prices survey in the Gauteng province in South Africa [Internet]. 2004. Available from: http://www.haiweb.org/medicineprices/surveys/200411ZAG/survey_report.pdf
    Paper not yet in RePEc: Add citation now

Cocites

Documents in RePEc which have cited the same bibliography

  1. Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America. (2022). Vogler, S ; Moye-Holz, Daniela.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00670-4.

    Full description at Econpapers || Download paper

  2. Beyond price: the effects of non-financial barriers on access to drugs and health outcomes. (2021). LEVAGGI, ROSELLA ; Montefiori, Marcello ; Leporatti, Lucia.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:22:y:2021:i:4:d:10.1007_s10198-021-01270-8.

    Full description at Econpapers || Download paper

  3. Stakeholder point of view on prescription drug affordability - a systematic literature review and content analysis. (2021). Johnson, Erwin C ; Kowal, Stacey ; Singh, Rajpal ; Uyei, Jennifer ; Rachev, Boris.
    In: Health Policy.
    RePEc:eee:hepoli:v:125:y:2021:i:9:p:1158-1165.

    Full description at Econpapers || Download paper

  4. Managing complex adaptive systems: A resource/agent qualitative modelling perspective. (2021). Morton, Alec ; Howick, Susan ; Kazakov, Rossen .
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:290:y:2021:i:1:p:386-400.

    Full description at Econpapers || Download paper

  5. Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition. (2020). Pertile, Paolo ; LEVAGGI, ROSELLA.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-019-00541-z.

    Full description at Econpapers || Download paper

  6. Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US. (2020). Mossialos, Elias ; Shearer, Emily ; Salas-Vega, Sebastian .
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:258:y:2020:i:c:s0277953620302616.

    Full description at Econpapers || Download paper

  7. The effect of inertia on brand-name versus generic drug choices. (2020). Kobayashi, Yasuki ; Hara, Konan ; Ito, Yuki.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:172:y:2020:i:c:p:364-379.

    Full description at Econpapers || Download paper

  8. Hospital reforms in 11 Central and Eastern European countries between 2008 and 2019: a comparative analysis. (2020). Velkey, Z ; Smatana, M ; Scintee, S G ; Murauskiene, L ; Habicht, T ; Dakula, A ; Dimova, A ; Bryndova, L ; Behmane, D ; Albreht, T ; Quentin, W ; Dubas-Jakobczyk, K.
    In: Health Policy.
    RePEc:eee:hepoli:v:124:y:2020:i:4:p:368-379.

    Full description at Econpapers || Download paper

  9. Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe. (2020). Kanavos, Panos ; Mills, Mackenzie.
    In: Health Policy.
    RePEc:eee:hepoli:v:124:y:2020:i:3:p:239-251.

    Full description at Econpapers || Download paper

  10. Evaluation of efficiency enhancement in Iran Health Insurance Organization: a policy brief for pharmaceutical cost containment. (2020). Afsharmanesh, Gita ; Moghaddam, Mahyar Polroudi ; Yousefi, Nazila ; Peiravian, Farzad.
    In: International Journal of Health Planning and Management.
    RePEc:bla:ijhplm:v:35:y:2020:i:6:p:1503-1511.

    Full description at Econpapers || Download paper

  11. Reference Pricing and Parallel Imports: Evidence from Germany. (2019). Birg, Laura.
    In: Annual Conference 2019 (Leipzig): 30 Years after the Fall of the Berlin Wall - Democracy and Market Economy.
    RePEc:zbw:vfsc19:203666.

    Full description at Econpapers || Download paper

  12. Parallel imports and manufacturer rebates: Evidence from Germany. (2019). Birg, Laura.
    In: Center for European, Governance and Economic Development Research Discussion Papers.
    RePEc:zbw:cegedp:363.

    Full description at Econpapers || Download paper

  13. Reference pricing and parallel imports: Evidence from Germany. (2019). Birg, Laura.
    In: Center for European, Governance and Economic Development Research Discussion Papers.
    RePEc:zbw:cegedp:362.

    Full description at Econpapers || Download paper

  14. Pricing of HPV vaccines in European tender-based settings. (2019). Berkhof, Johannes ; Bogaards, Johannes A ; Qendri, Venetia.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-0996-9.

    Full description at Econpapers || Download paper

  15. The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014. (2019). Suleman, Fatima ; Moodley, Rajatheran.
    In: PLOS ONE.
    RePEc:plo:pone00:0219690.

    Full description at Econpapers || Download paper

  16. Fair prices for medicines? Exploring competent authorities’ and public payers’ preferences on pharmaceutical policies. (2019). Vogler, Sabine.
    In: Empirica.
    RePEc:kap:empiri:v:46:y:2019:i:3:d:10.1007_s10663-019-09446-5.

    Full description at Econpapers || Download paper

  17. Parallel imports, price controls, and innovation. (2019). Zenger, Hans ; Sauri, Lluis ; Reisinger, Markus.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:66:y:2019:i:c:p:163-179.

    Full description at Econpapers || Download paper

  18. Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. (2019). Park, Sylvia ; Choi, Sang-Eun ; Bae, Seungjin ; Kwon, Hye-Young ; Kim, Jin Hyun ; Lee, Eui-Kyung .
    In: Health Policy.
    RePEc:eee:hepoli:v:123:y:2019:i:4:p:388-392.

    Full description at Econpapers || Download paper

  19. Parallel Imports and Manufacturer Rebates. (2018). Birg, Laura.
    In: Annual Conference 2018 (Freiburg, Breisgau): Digital Economy.
    RePEc:zbw:vfsc18:181646.

    Full description at Econpapers || Download paper

  20. Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage. (2018). Gialama, Fotini ; Correa, Jose Otavio ; Holtorf, Anke-Peggy ; Maniadakis, Nikolaos ; Wijaya, Kalman.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:16:y:2018:i:5:d:10.1007_s40258-018-0405-7.

    Full description at Econpapers || Download paper

  21. Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Paterson, Kenneth R ; Vogler, Sabine.
    In: PharmacoEconomics - Open.
    RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1.

    Full description at Econpapers || Download paper

  22. Defining and Measuring the Affordability of New Medicines: A Systematic Review. (2017). Shalet, Natalie ; Overton, Paul M ; Terkola, Robert ; Antoanzas, Fernando ; Postma, Maarten.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0514-4.

    Full description at Econpapers || Download paper

  23. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie ; Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees .
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

    Full description at Econpapers || Download paper

  24. Ethical Hurdles in the Prioritization of Oncology Care. (2017). Cunningham, David ; Castanier, Jean-Claude ; Wong, Olivier ; Capri, Stefano ; Walker, Andrew ; Groot, Folkert ; Shalet, Natalie ; Rupprecht, Christoph J ; Sola-Morales, Oriol ; Levin, Lars-Ke ; Herholz, Harald ; Flume, Mathias ; Flamion, Bruno.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:15:y:2017:i:2:d:10.1007_s40258-016-0288-4.

    Full description at Econpapers || Download paper

  25. Why Pharmaceutical Exports from India to Europe Grew During Economic Crisis?. (2017). .
    In: Management and Labour Studies.
    RePEc:sae:manlab:v:42:y:2017:i:1:p:39-58.

    Full description at Econpapers || Download paper

  26. Reference pricing with endogenous generic entry. (2016). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:50:y:2016:i:c:p:312-329.

    Full description at Econpapers || Download paper

  27. Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015. (2016). Zimmermann, Nina ; Vogler, Sabine ; de Joncheere, Kees .
    In: Health Policy.
    RePEc:eee:hepoli:v:120:y:2016:i:12:p:1363-1377.

    Full description at Econpapers || Download paper

  28. Assessment of the Price–Volume Agreement Program in South Korea. (2016). Han, Euna ; Lee, Eui-Kyung ; Park, Sun-Young.
    In: Health Policy.
    RePEc:eee:hepoli:v:120:y:2016:i:10:p:1209-1215.

    Full description at Econpapers || Download paper

  29. Bulgaria Health Financing. (2015). Bank, World.
    In: World Bank Other Operational Studies.
    RePEc:wbk:wboper:22964.

    Full description at Econpapers || Download paper

  30. Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform. (2015). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt ; Straumeauthor-Email, Odd Rune .
    In: NIPE Working Papers.
    RePEc:nip:nipewp:6/2015.

    Full description at Econpapers || Download paper

  31. Reference pricing with endogenous generic entry. (2015). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt.
    In: NIPE Working Papers.
    RePEc:nip:nipewp:2/2015.

    Full description at Econpapers || Download paper

  32. Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform. (2015). Brekke, Kurt R. ; Straume, Odd Rune ; Canta, Chiara.
    In: NIPE Working Papers.
    RePEc:nip:nipewp:06/2015.

    Full description at Econpapers || Download paper

  33. Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform.. (2015). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2015_011.

    Full description at Econpapers || Download paper

  34. Reference pricing with endogenous generic entry.. (2015). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2015_004.

    Full description at Econpapers || Download paper

  35. Price regulation and parallel imports of pharmaceuticals. (2015). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:129:y:2015:i:c:p:92-105.

    Full description at Econpapers || Download paper

  36. General Practitioners’ intention to prescribe and prescribing patterns in selected European settings: The OTCSOCIOMED project. (2015). Vlek, Jii ; Tsiantou, Vasiliki ; Samoutis, George ; Martinez, Luc ; Klimkova, Martina ; Faresjo, Tomas ; Alper, Zuleyha ; Agius, Dominic ; Saridaki, Aristoula ; Papadakaki, Maria ; Bertsias, Antonis ; Lionis, Christos ; Moschandreas, Joanna .
    In: Health Policy.
    RePEc:eee:hepoli:v:119:y:2015:i:9:p:1265-1274.

    Full description at Econpapers || Download pap

  37. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997–2013. (2015). Fuksa, Leos ; Vytrisalova, Magda ; Vocelka, Milan .
    In: Health Policy.
    RePEc:eee:hepoli:v:119:y:2015:i:9:p:1255-1264.

    Full description at Econpapers || Download paper

  38. Effects of pharmaceutical cost containment policies on doctors’ prescribing behavior: Focus on antibiotics. (2015). Han, Euna ; Park, Sylvia ; Kim, Nam-Soon ; Chae, Su-Mi .
    In: Health Policy.
    RePEc:eee:hepoli:v:119:y:2015:i:9:p:1245-1254.

    Full description at Econpapers || Download paper

  39. Price Regulation and Parallel Imports of Pharmaceuticals. (2015). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_5469.

    Full description at Econpapers || Download paper

  40. The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland. (2014). Ahola, Elina ; Saastamoinen, Leena ; Mikkola, Hennamari ; Martikainen, Jaana ; Koskinen, Hanna .
    In: Health Economics Review.
    RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-10:10.1186/s13561-014-0009-3.

    Full description at Econpapers || Download paper

  41. Paying for Formerly Free Medicines in Spain After 1 Year of Co-Payment: Changes in the Number of Dispensed Prescriptions. (2014). Rodriguez-Feijoo, Santiago ; Puig-Junoy, Jaume ; Lopez-Valcarcel, Beatriz .
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:12:y:2014:i:3:p:279-287.

    Full description at Econpapers || Download paper

  42. A review of the pharmaceutical market in Portugal. (2014). Vilares, Hugo ; Pereira, Manuel.
    In: Economic Bulletin and Financial Stability Report Articles and Banco de Portugal Economic Studies.
    RePEc:ptu:bdpart:b201411.

    Full description at Econpapers || Download paper

  43. Prescription Patterns of Pharmaceuticals. (2014). Gonalves, Ana Sofia .
    In: GEE Papers.
    RePEc:mde:wpaper:0054.

    Full description at Econpapers || Download paper

  44. Pricing schemes for new drugs: A welfare analysis. (2014). LEVAGGI, ROSELLA.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:102:y:2014:i:c:p:69-73.

    Full description at Econpapers || Download paper

  45. Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark. (2014). Ullrich, Hannes ; Kaiser, Ulrich ; Ronde, Thomas ; Mendez, Susan J..
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:36:y:2014:i:c:p:174-187.

    Full description at Econpapers || Download paper

  46. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. (2014). Goranitis, Ilias ; Siskou, Olga ; Liaropoulos, Lycourgos .
    In: Health Policy.
    RePEc:eee:hepoli:v:117:y:2014:i:3:p:279-284.

    Full description at Econpapers || Download paper

  47. Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices. (2014). van de Vooren, Katelijne ; Ghislandi, Simone ; Duranti, Silvy ; Curto, Sandro ; Garattini, Livio.
    In: Health Policy.
    RePEc:eee:hepoli:v:116:y:2014:i:2:p:182-187.

    Full description at Econpapers || Download paper

  48. IfW-Krisencheck: Alles wieder gut in Griechenland?. (2013). Laaser, Claus-Friedrich ; Schrader, Klaus ; Bencek, David.
    In: Kiel Discussion Papers.
    RePEc:zbw:ifwkdp:522-523.

    Full description at Econpapers || Download paper

  49. Generic-branded drug competition and the price for pharmaceuticals in procurement auctions. (2013). Barbosa, Klenio ; Arvate, Paulo ; Barbosa, Klenio de Souza, ; Gambardella, Dante .
    In: Textos para discussão.
    RePEc:fgv:eesptd:333.

    Full description at Econpapers || Download paper

  50. Ireland: Pharmaceutical Prices, Prescribing Practices and Usage of Generics in a Comparative Context. (2013). Nolan, Anne ; Gorecki, Paul K. ; Brick, Aoife .
    In: Research Series.
    RePEc:esr:resser:rs32.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-01-05 22:49:38 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.